Th17 Cells in MS and Experimental Autoimmune Encephalomyelitis

Area of Science:

• Neuroimmunology
• Autoimmune Diseases
• Central Nervous System (CNS) Disorders

Background:

• Multiple sclerosis (MS) is traditionally viewed as a T helper 1 (Th1) cell-mediated autoimmune disease.
• Experimental autoimmune encephalomyelitis (EAE) has been the primary model for studying MS.
• Recent research highlights a distinct T cell lineage, T helper 17 (Th17) cells, as potentially crucial in CNS autoimmunity.

Purpose of the Study:

• To review the current literature on the role of Th17 cells in CNS autoimmune diseases.
• To summarize evidence supporting Th17 cells as key effectors in multiple sclerosis.
• To explore factors influencing Th17 cell priming, expansion, differentiation, and activation in the context of CNS autoimmunity.

Main Methods:

• Literature review of studies in multiple sclerosis patients.
• Analysis of findings from experimental autoimmune encephalomyelitis (EAE) mouse models.
• Synthesis of research on endogenous and exogenous factors affecting Th17 cell responses.

Main Results:

• Accumulating evidence suggests Th17 cells, characterized by interleukin-17 production, are critical effector cells in CNS autoimmune diseases.
• Studies in both MS patients and EAE models support the significant role of Th17 cells.
• Current research focuses on identifying factors that regulate Th17 cell development and function in the CNS.

Conclusions:

• Th17 cells represent a significant effector population in CNS autoimmune diseases like multiple sclerosis.
• Understanding the regulation of Th17 cells is crucial for developing targeted therapies for MS.
• This review consolidates evidence on Th17 cell involvement, guiding future research directions.